Skip to main content
. 2022 Jun 17;13:846844. doi: 10.3389/fpsyt.2022.846844

TABLE 2.

Baseline characteristics of the population.

PWID with psychiatric conditions (n = 130) Control population (n = 136) p-value1
Socio-demographic data
Sex, Male and transgender n(%) 120 (92.3) 127 (93.4) 0.73
Age, mean(SD) 45.3 (8.5) 40.9 (7.7) <0.001
Heroin, number of years practicing injection
<5 years 7 (5.4) 9 (6.6) 0.01
5 to 10 years 20 (15.4) 43 (31.6)
10 to 15 years 36 (27.7) 34 (25.0)
≥15 years 67 (51.5) 50 (36.8)
Heroin, frequency of injection during the month preceding the interview 1.00
Less than once per day 43 (33.1) 45 (33.1)
Daily 87 (66.9) 91 (66.9)
Methamphetamine, Positive urine test 38 (29.2) 37 (27.2) 0.71
Methamphetamine, number of years of consumption 0.11
No consumption 28 (21.7) 45 (33.1)
<2 years 26 (20.2) 19 (14.0)
2 to 5 years 33 (25.6) 38 (27.9)
≥5 years 42 (32.6) 34 (25.0)
Methamphetamine, frequency of consumption during the month preceding the interview 0.73
<4 times a month 100 (76.9) 107 (78.7)
≥4 times a month 30 (23.1) 29 (21.3)
Methadone (Positive urine test) 71 (54.5) 85 (62.5) 0.19
Excessive alcohol consumption 45 (34.6) 32 (23.5) 0.05
Poly substance use 0.18
0 24 (18.5) 28 (20.6)
1 58 (44.6) 72 (52.9)
≥2 48 (36.9) 36 (26.5)
Viral infections
Positive HCV RNA 81 (62.3) 82 (60.3) 0.74
Positive HIV serology 47 (36.1) 57 (41.9) 0.34
HIV pos. receiving ARV treatment 33 (70.2) 43 (75.4) 0.26

1Chi-squared test or t-test; HCV, hepatitis C; and HIV, human immunodeficiency virus.